Apotex Surrenders In Plavix Patent Saga
Sanofi and Bristol-Myers revealed the news on Tuesday, noting that they had also approached Dr. Reddy’s Laboratories with a similar arrangement.
Co-marketed with Bristol-Myers Squibb, Plavix is Sanofi-Aventis's ground-breaking stroke medication.
Since 2002, Apotex and India-based Dr. Reddy’s have been seeking to strip Sanofi of the Plavix...
To view the full article, register now.